Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,808 | 1,851 | 98.0% |
| Education | $472.08 | 14 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,537 | 164 | $0 (2024) |
| Novo Nordisk Inc | $2,511 | 252 | $0 (2024) |
| PFIZER INC. | $1,853 | 169 | $0 (2024) |
| ABBVIE INC. | $1,593 | 186 | $0 (2024) |
| Lilly USA, LLC | $1,345 | 87 | $0 (2024) |
| Amgen Inc. | $1,286 | 88 | $0 (2024) |
| Astellas Pharma US Inc | $1,198 | 53 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,005 | 119 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,000 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $933.53 | 113 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,009 | 190 | ABBVIE INC. ($473.92) |
| 2023 | $2,766 | 204 | AbbVie Inc. ($400.86) |
| 2022 | $3,034 | 208 | Novo Nordisk Inc ($456.35) |
| 2021 | $3,167 | 238 | AbbVie Inc. ($350.82) |
| 2020 | $2,791 | 213 | Allergan, Inc. ($380.10) |
| 2019 | $3,019 | 269 | AstraZeneca Pharmaceuticals LP ($369.16) |
| 2018 | $2,854 | 292 | AstraZeneca Pharmaceuticals LP ($374.15) |
| 2017 | $2,641 | 251 | AstraZeneca Pharmaceuticals LP ($309.72) |
All Payment Transactions
1,865 individual payment records from CMS Open Payments — Page 1 of 75
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $30.79 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Biological | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Biological | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: VACCINE | ||||||
| 10/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: Bone Health | ||||||
| 10/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: PAIN | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/07/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $33.88 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 723 | 899 | $148,129 | $61,678 |
| 2022 | 10 | 846 | 1,024 | $153,448 | $67,972 |
| 2021 | 11 | 845 | 1,027 | $155,208 | $66,403 |
| 2020 | 16 | 1,036 | 1,306 | $186,848 | $70,317 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 222 | 351 | $80,730 | $25,771 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 176 | $27,280 | $10,307 | 37.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 75 | 75 | $17,850 | $9,341 | 52.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 78 | 78 | $7,176 | $5,607 | 78.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $5,282 | $5,176 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 85 | 85 | $2,125 | $2,083 | 98.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $4,081 | $1,702 | 41.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 65 | 65 | $2,730 | $1,158 | 42.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 19 | $475.00 | $465.50 | 98.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 20 | $400.00 | $68.20 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 252 | $57,960 | $19,177 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 127 | 127 | $30,226 | $16,455 | 54.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 178 | 260 | $40,300 | $13,856 | 34.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 30 | 30 | $8,340 | $8,179 | 98.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 76 | 76 | $6,992 | $5,141 | 73.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 114 | 114 | $4,788 | $2,122 | 44.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 81 | 81 | $2,025 | $1,960 | 96.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 29 | 29 | $725.00 | $711.50 | 98.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 32 | $1,632 | $296.53 | 18.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 21 | 23 | $460.00 | $75.82 | 16.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 181 | 261 | $60,030 | $19,977 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 150 | 150 | $35,700 | $19,929 | 55.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 164 | 264 | $40,920 | $14,335 | 35.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 64 | 64 | $5,888 | $4,177 | 70.9% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 11 | 11 | $2,728 | $2,644 | 96.9% |
About Dr. Dana Brown, M.D
Dr. Dana Brown, M.D is a Family Medicine healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306809439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dana Brown, M.D has received a total of $23,280 in payments from pharmaceutical and medical device companies, with $3,009 received in 2024. These payments were reported across 1,865 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($22,808).
As a Medicare-enrolled provider, Brown has provided services to 3,450 Medicare beneficiaries, totaling 4,256 services with total Medicare billing of $266,371. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Fredericksburg, VA
- Active Since 04/10/2006
- Last Updated 08/11/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1306809439
Products in Payments
- FARXIGA (Drug) $1,634
- Ozempic (Drug) $966.14
- JARDIANCE (Drug) $832.12
- UBRELVY (Drug) $747.45
- REXULTI (Drug) $747.02
- NURTEC ODT (Drug) $710.06
- EMGALITY (Drug) $604.87
- VRAYLAR (Drug) $602.67
- JANUVIA (Drug) $532.22
- BREZTRI (Drug) $511.60
- EVENITY (Biological) $505.97
- XARELTO (Drug) $479.87
- SOLIQUA 100/33 (Biological) $479.45
- QULIPTA (Drug) $451.67
- Victoza (Drug) $399.13
- Rybelsus (Drug) $393.36
- PREVNAR - 13 (Biological) $391.24
- XIFAXAN (Drug) $366.21
- Aimovig (Biological) $348.17
- TRELEGY ELLIPTA (Drug) $330.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fredericksburg
Julie Floyd, M.d, M.D
Family Medicine — Payments: $22,869
Wilson Cook, M.d, M.D
Family Medicine — Payments: $19,339
Rafael Hernandez, M.d, M.D
Family Medicine — Payments: $19,174
Dr. Steven Ma, Md, MD
Family Medicine — Payments: $14,912
Dr. Nelson Henry, M.d, M.D
Family Medicine — Payments: $14,770
Donna Gamache, M.d, M.D
Family Medicine — Payments: $11,509